The Klinique Medical Clinic PCL (BKK:KLINIQ)
Thailand
· Delayed Price · Currency is THB 26.75
+0.75 (2.88%)
Mar 6, 2026, 4:35 PM ICT
BKK:KLINIQ Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 3,556 | 2,983 | 2,285 | 1,639 | 949.93 | Upgrade
|
| Revenue | 3,556 | 2,983 | 2,285 | 1,639 | 949.93 | Upgrade
|
| Revenue Growth (YoY) | 19.22% | 30.55% | 39.41% | 72.54% | -5.06% | Upgrade
|
| Cost of Revenue | 1,760 | 1,440 | 1,050 | 716.07 | 391.16 | Upgrade
|
| Gross Profit | 1,796 | 1,543 | 1,235 | 922.97 | 558.77 | Upgrade
|
| Selling, General & Admin | 1,333 | 1,154 | 903.07 | 674.28 | 407.68 | Upgrade
|
| Other Operating Expenses | -13.44 | -9.54 | -13.2 | -7.06 | -2.15 | Upgrade
|
| Operating Expenses | 1,319 | 1,144 | 889.88 | 667.22 | 405.53 | Upgrade
|
| Operating Income | 477.21 | 398.58 | 345.16 | 255.75 | 153.24 | Upgrade
|
| Interest Expense | -26.34 | -23.9 | -15.1 | -10.66 | -4.32 | Upgrade
|
| Interest & Investment Income | - | 16.25 | 20.17 | 1.11 | 0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 10.17 | - | - | - | - | Upgrade
|
| Pretax Income | 461.05 | 390.92 | 350.22 | 246.2 | 148.98 | Upgrade
|
| Income Tax Expense | 97 | 68.73 | 61.6 | 40.71 | 19.73 | Upgrade
|
| Earnings From Continuing Operations | 364.05 | 322.19 | 288.62 | 205.49 | 129.26 | Upgrade
|
| Minority Interest in Earnings | -0.35 | - | - | - | - | Upgrade
|
| Net Income | 363.7 | 322.19 | 288.62 | 205.49 | 129.26 | Upgrade
|
| Net Income to Common | 363.7 | 322.19 | 288.62 | 205.49 | 129.26 | Upgrade
|
| Net Income Growth | 12.88% | 11.63% | 40.45% | 58.98% | -10.67% | Upgrade
|
| Shares Outstanding (Basic) | 220 | 220 | 220 | 170 | 160 | Upgrade
|
| Shares Outstanding (Diluted) | 220 | 220 | 220 | 170 | 160 | Upgrade
|
| Shares Change (YoY) | 0.19% | - | 29.64% | 6.06% | - | Upgrade
|
| EPS (Basic) | 1.65 | 1.46 | 1.31 | 1.21 | 0.81 | Upgrade
|
| EPS (Diluted) | 1.65 | 1.46 | 1.31 | 1.21 | 0.81 | Upgrade
|
| EPS Growth | 12.67% | 11.63% | 8.34% | 49.89% | -10.67% | Upgrade
|
| Free Cash Flow | 360.62 | -19.7 | 19.39 | 182.17 | 165.64 | Upgrade
|
| Free Cash Flow Per Share | 1.64 | -0.09 | 0.09 | 1.07 | 1.03 | Upgrade
|
| Dividend Per Share | - | 1.400 | 1.300 | 0.500 | 0.356 | Upgrade
|
| Dividend Growth | - | 7.69% | 160.00% | 40.33% | 18.77% | Upgrade
|
| Gross Margin | 50.51% | 51.71% | 54.05% | 56.31% | 58.82% | Upgrade
|
| Operating Margin | 13.42% | 13.36% | 15.10% | 15.60% | 16.13% | Upgrade
|
| Profit Margin | 10.23% | 10.80% | 12.63% | 12.54% | 13.61% | Upgrade
|
| Free Cash Flow Margin | 10.14% | -0.66% | 0.85% | 11.11% | 17.44% | Upgrade
|
| EBITDA | 810.33 | 553.05 | 539.76 | 329 | 205.17 | Upgrade
|
| EBITDA Margin | 22.79% | 18.54% | 23.62% | 20.07% | 21.60% | Upgrade
|
| D&A For EBITDA | 333.12 | 154.47 | 194.61 | 73.26 | 51.93 | Upgrade
|
| EBIT | 477.21 | 398.58 | 345.16 | 255.75 | 153.24 | Upgrade
|
| EBIT Margin | 13.42% | 13.36% | 15.10% | 15.60% | 16.13% | Upgrade
|
| Effective Tax Rate | 21.04% | 17.58% | 17.59% | 16.54% | 13.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.